I want to make sure that our bio-similars capture a huge market share and help cancer patients around the world, which we are already doing in the developing world because we didn't have access to these drugs. Biocon enjoys a large reputation of giving them high-quality cancer drug.
— Kiran Mazumdar-Shaw